Volume 33, Nº 1, January and february 2020
DOI: http://www.dx.doi.org/10.5935/2359-4802.20190087
EDITORIAL
Diabetes Mellitus, Insulin Use, and Infective Endocarditis
Rubens Antunes Cruz Filho
The prevalence of diabetes mellitus (DM) is very high in Brazil and worldwide. It is estimated that there are now more than 12 million diabetics in Brazil, not counting those who already have the disease but have not yet been diagnosed. Since the introduction of insulin, the treatment of DM has been constantly changing, according to treatment guidelines proposed by diabetes societies, from the diagnosis to more advanced stages of the disease. More stable insulins, as well as incretin-based therapy for subcutaneous use, have been proposed in the treatment of type 2 DM patients. These therapies have not only contributed to the better treatment of the most prevalent type of diabetes, but also introduced the use of a parenteral medication other than insulin.
Keywords: Diabetes Mellitus/physiopathology; Infectious Endocarditis; Insulin; Staphylococcus Aureus; Mortality/ Morbidity.